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 Are environmental exposures to selenium, heavy metals, and 
pesticides risk factors for amyotrophic lateral sclerosis ? 
degeneration of upper and lower motor neurons in both motor 
cortex and spinal cord, leading to progressive paralysis and 
death due to respiratory failure (unless mechanical ventilation 
is supplied). The etiology of this most common form of motor 
neuron disease (MND), nearly 140 years after its description 
by Charcot, still remains unknown. Both environmental and 
genetic factors have been involved in the familial and in the 
more common sporadic form, the incidence of which might 
be increasing according to recent reports  (1, 2) and appears 
to have uneven spatial distribution  (3) . Environmental risk 
factors for which some epidemiological and clinical evidence 
exists include neurotropic viruses, cyanobacterial toxins, 
magnetic fi elds, and several chemicals  (4 – 6) . In this review, 
we have summarized and discussed the evidence supporting 
a role of environmental exposure to chemical substances in 
ALS etiology, focusing on a metalloid [selenium (Se)], three 
heavy metals [mercury (Hg), cadmium (Cd), and lead (Pb)], 
and pesticides. 
 Selenium 
 Se is a trace element commonly found in very low concen-
trations in the environment and occurs naturally in several 
organic and inorganic species. The element is of paramount 
importance in both toxicological and nutritional aspects 
 (7 – 10) . The main source of Se intake in humans is the diet, 
although sometimes ambient air in occupational settings and 
in areas characterized by large combustion of coal  (11, 12) 
or in drinking water  (10, 13) can become relevant sources 
of exposure. The exact role of Se in human health is still 
not well defi ned and highly controversial  (10, 14) , despite 
recent advancements in the understanding of its dichotomous 
involvement in human health and disease  (10, 12, 14 – 17) . 
ALS is among the human diseases suggested to derive from 
excess Se exposure on the basis of two epidemiological stud-
ies that found an increased risk of ALS associated with resi-
dence in a seleniferous area or with consumption of drinking 
water with unusually high levels of inorganic hexavalent Se. 
Laboratory investigations have provided supportive evidence 
of a cause-effect relation  (18, 19) . 
 Se has long been recognized as a wide-spectrum neurotoxic 
agent, based on laboratory studies. In the rat, Se compounds 
(in most cases, in its inorganic tetravalent form, selenite) were 
observed to enter the central nervous system (CNS) from 
peripheral blood vessels, showing an enhanced affi nity for 
the spinal cord and the hypothalamus  (20) . The metalloid can 
alter dopamine levels in brain, exert hypothermic and nocice-
ptive responses, impair locomotor activity  (21) , interfere with 
prostaglandin D synthesis and activity  (22) , inhibit at very 
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 Abstract 
 The etiology of sporadic amyotrophic lateral sclerosis (ALS), 
the most common form of this degenerative disease of the 
motor neurons, is still unknown, despite extensive inves-
tigation of several genetic and environmental potential risk 
factors. We have reviewed laboratory and epidemiological 
studies assessing the role of exposure to neurotoxic chemicals 
(metalloid selenium; heavy metals mercury, cadmium, and 
lead; pesticides) in ALS etiology by summarizing the results 
of these investigations and examining their strengths and 
limitations. Despite limitations in the exposure assessment 
methodologies typically used in human studies, we found 
suggestive epidemiological evidence and biologic plausibility 
for an association between ALS and antecedent overexposure 
to environmental selenium and pesticides. The relation with 
mercury, cadmium, and lead appears weaker. 
 Keywords:  heavy metals;  motor neuron disease;  neurotoxins; 
 pesticides. 
 Introduction 
 Amyotrophic lateral sclerosis (ALS) is a rare and extremely 
severe human neurodegenerative disease characterized by a 
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low levels  δ -aminolevulinate dehydratase in the CNS  (23) , 
and affect the latencies and conduction velocity distribution 
of sciatic nerve fi bers  (24) . Se compounds increase the activity 
of lactato dehydrogenase and the amount of thiobarbituric 
acid reactive substances in the rat brain  (25) , impair gluta-
mate uptake  (26, 27) , and inhibit succinic dehydrogenase, 
acetylcholine esterase, and Na/K ATPase  (28) . In cultured 
primary mouse cortical neurons  (29) , Se levels as low as 8 
 μ g/L and even less in its inorganic tetravalent form (selenite) 
induced apoptosis. Selenite was shown to provoke abnor-
malities in dopamine metabolites, lipids, and thiobarbituric 
acid-reactive substances in the striatum  (19, 30) and cardio-
respiratory effects, hind-limb paralysis, and death after intra-
venous administration  (31) . Se may also be responsible for 
the accumulation of a Hg-Se complex in CNS areas  (32) , with 
a consequent possible release of these toxic elements into the 
CNS over time. Depending on its concentration and chemical 
form, Se toxicity in cultured nervous system cells might be 
additive or antagonistic to Hg toxicity  (33) . 
 Se compounds are able to damage mitochondrial func-
tions and integrity  (34, 35) , a pattern that might be involved 
in ALS etiopathogenesis  (36) . Several lines of evidence sup-
port the view that mitochondria are affected in the course of 
motor neuron degeneration and that mitochondrial dysfunc-
tion may actively participate in the demise of motor neurons. 
Mitochondrial abnormalities have been described in ALS 
patients. In vitro studies using rabbit aorta have shown Se 
compounds to damage vascular smooth muscle reactivity 
by inhibiting both contracting and relaxing properties  (37) , 
which might also be related to the amyotrophic process char-
acterizing ALS. Se also inhibits purifi ed human squalene 
monooxygenase, a key enzyme for cholesterol biosynthesis 
 (38) . Inhibition of this enzyme leads to a peripheral demyeli-
nating neuropathy in rats, which occurs secondary to a sys-
temic block in cholesterol synthesis  (39) . 
 All the above-mentioned studies demonstrate the potential 
neurotoxicity of Se in the experimental animal. Nevertheless, 
the strongest evidence of a biological plausibility for the 
Se-ALS association emerges from veterinary medicine studies 
in swine, which showed that Se intoxication (due to inorganic 
Se compounds in most cases) results in a selective necrosis 
of the ventral horns of the spinal cord and other CNS regions 
 (40 – 45) . The induction of symmetrical poliomyelomalacia in 
pigs was enhanced by inorganic Se compared with organic 
Se, despite the higher Se tissue content after the administra-
tion of the organic form  (46) . The occurrence of polioenceph-
alomyelomalacia has also been experimentally induced in 
cattle following the administration of inorganic Se as selenite; 
neurological signs included trembling of skeletal muscles, 
enhanced by exercise, which led the treated animals to shiver 
 (47) , resembling the blind-staggers originally described in 
livestock from seleniferous areas in the USA  (12) . Sodium sel-
enite was found to be toxic to chicks, inducing neuromuscular 
blockade and tetanic spasm: the compound blocked axonal 
conduction and directly affected the muscle membrane by 
releasing Ca 2 +  from the sarcoplasmic reticulum  (18) . Selenite 
also inhibited neurotransmitter release and axonal conduc-
tion in a mouse phrenic nerve-diaphragm preparation  (48) . 
Morgan et al.  (49) have shown the capability of long-term 
Se exposure to impair locomotor activity and even to para-
lyze the nematode  Caenorhabditis elegans , likely due to a 
Se-induced generation of reactive oxygen species (ROS). 
 Overall, in the light of the above studies, Se appears to 
exert selective toxicity on the motor neurons in several animal 
species at least. The same pathological feature characterizes 
ALS and seems to be a distinctive feature of Se compared 
with all other chemicals, to the best of our knowledge. Such 
neurotoxic effects of Se, however, may vary considerably 
according to the animal species and the chemical forms of the 
metalloid involved  (12, 14, 50) . 
 The key evidence linking Se to ALS, however, is based on 
epidemiological evidence arising from human studies. The 
fi rst investigation to suggest a relation between exposure to 
environmental Se and ALS was a report published in 1977 
by a physician in a private practice, Arthur Kilness, and the 
Harvard neurologist Fred Hochberg, who described the occur-
rence of a cluster of four cases of ALS among male ranchers 
within a sparsely populated South Dakota county (around 
4000 inhabitants) during an 11-year period  (51) . The authors 
also outlined the early veterinary medicine observations that 
showed the occurrence of the so-called blind-staggers disease 
in livestock chronically intoxicated with Se, as well as the 
fi nding of spinal cord degeneration in malformed embryos of 
hens characterized by excess Se intake, and remarked on the 
need to further investigate environmental Se as a potential 
risk factor for human ALS. This study had some limitations, 
however, such as the lack of a prespecifi ed area and period of 
the study and, more importantly, the possibility of ecological 
bias due to other environmental or genetic factors. 
 A few case-control studies were subsequently carried out to 
investigate the role of Se exposure in ALS etiology, although 
the lack of specifi c biomarkers of long-term exposure to the 
metalloid, as well as the severe impairment of health status 
occurring during early disease progression, substantially 
hampered the assessment of long-term antecedent exposure in 
patients. Two studies found higher Se levels in the spinal cord 
of ALS patients compared with controls  (52, 53) , whereas 
in two Italian studies, blood and toenail Se concentrations 
were not increased in such patients  (54, 55) . The results of 
these studies also suggest that the nutritional status of patients 
might severely alter the circulating Se levels and, therefore, 
that case-control studies lacking long-term indicators of 
exposure are unsuitable to investigate the Se-ALS relation. 
Furthermore, no studies were conducted on the possible rela-
tion between the different Se chemical forms and ALS risk, 
which further hinders our ability to assess this issue, consid-
ering the differences in the biological activity and toxicity of 
the different Se compounds. Other observations from selenif-
erous areas of China indicated the potential of environmental 
Se to induce slight to severe motor disorders in humans  (56, 
57) , although no such effect was recently reported in a popu-
lation the Brazilian Amazon characterized by high Se intake 
and which also has the highest Hg exposures reported in the 
world today  (58) . The authors noted that their results are not 
necessarily applicable to populations with lower Hg exposure 
and/or Se status. Signs of neurotoxicity were also detected 
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in Inuit children from Northern Quebec exposed to high 
levels of methyl-Hg, polychlorinated biphenyl, and Se, but in 
that case, the adverse effects were exerted on visual-evoked 
potentials  (59) . 
 Two studies carried out in a peculiar Italian area, where a 
limited population experienced intake of inorganic hexava-
lent Se (selenate) for several years, have provided new and 
suggestive evidence linking environmental Se with ALS 
 (60, 61) . The study area was Rivalta, a neighbor of the city 
of Reggio Emilia in Northern Italy (around 150,000 inhabit-
ants), where during the 1970s and the 1980s, the public water 
supply system had to be separated from the remaining system 
due to technical reasons. The Rivalta aqueduct was connected 
to two local wells providing, as detected several years later, 
water with an unusually high content of Se (around 8  μ g/L) 
in its inorganic hexavalent form, selenate, the species usually 
found in underground waters (Figure  1 )  (62, 63) . Consumption 
of this high-Se drinking water by the local population (2000 
to  > 6000 residents, according to length of drinking water 
consumption) was unknown to both the population itself and 
the Municipal Water Authority until 1988  (60, 62, 64) . Only 
then, due to the disclosure of the high Se content, were the 
two wells disconnected from the municipal aqueduct, and the 
Rivalta aqueduct shared the water distributed in the remain-
ing municipality, containing  < 1  μ g Se/L. This situation pro-
vided the unusual design of a  ‘ natural experiment ’ , a situation 
of strong interest in epidemiology to investigate adverse 
health effects of toxicants that cannot be studied in planned 
experimental studies for obvious ethical reasons. Indeed, the 
exposed population was unaware of the high Se content of the 
drinking water they consumed, and no other chemical fea-
tures differentiated the tap water distributed in Rivalta from 
the tap water supplied to the remaining municipality. The sub-
jects consuming the high-Se drinking water in Rivalta and the 
remaining municipal population also appeared to be consid-
erably similar regarding their socioeconomic characteristics 
 (62, 63) . This situation provided an optimal setting to per-
form a cohort study, originally designed under the hypothesis 
that a higher Se intake in Rivalta might be associated with 
benefi cial effects on cancer and cardiovascular risk  (64, 65) 
but later including other adverse effects, such as ALS inci-
dence in the follow-up  (60) . Long-term consumption of the 
high-Se drinking water was associated with a strong increase 
in ALS risk [4.2, 95 % confi dence interval (CI) 1.2 – 10.8], 
which was even higher when we limited the analysis to the 
2065 individuals having the longest exposure (8.9, 95 % CI, 
2.4 – 22.8)  (60) . Several years after this report, an analysis of 
the Se-ALS relation was repeated in the same locale, with two 
key methodological variations to the study design: extension 
of the analysis to any source and period of consumption of 
high-Se drinking water and choice of a case-control approach. 
The ALS incidence was assessed among the exposed subjects 
in the period 1995 – 2006, immediately subsequent to that 
examined in the prior cohort study (1986 – 1994)  (61) . The 
Wells
Rivalta area
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N
 Figure 1  Map of the Rivalta area in the Reggio Emilia municipality (extension, 231.6 km 2 ; population,  ∼ 150,000), where tap water with 
unusually high content of inorganic hexavalent Se from the two local wells, 1 and 2, was distributed from 1972 to 1988. 
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results of this investigation confi rmed an association between 
drinking water (inorganic) Se and ALS, showing a relative 
risk (RR) of 5.4 (95 % CI, 1.1 – 26) for the consumption of 
tap water with Se  ≥ 1  μ g/L after adjustment for potential con-
founders and evidence of a dose-response relation between 
the long-term intake of inorganic Se and disease risk  (61) . 
Overall, the results confi rmed the likelihood of a selec-
tive relation between Se and ALS in the municipal popula-
tion under study, suggesting that major sources of bias were 
unlikely to occur. 
 Thus, the epidemiological evidence suggests that Se may 
cause or contribute to triggering ALS. As high Se areas are 
detected in various parts of the world  (7, 10, 11) and occupa-
tional exposures to Se compounds may occur, further epide-
miological studies for the ascertainment of this issue appear 
feasible and should be seriously pursued  (12) . In line with 
the usual paradoxes characterizing Se research, we should 
note that due to the antioxidant activity of the Se-containing 
enzymes glutathione peroxidases, the metalloid has also been 
considered a potential tool in the therapy of the disease, but a 
careful analysis of the epidemiological data has not provided 
convincing evidence of such an effect  (66) . 
 Mercury 
 The heavy metal Hg exists in a wide variety of physical 
states: elemental Hg, organic, and inorganic Hg compounds. 
The neurotoxic effects of elemental Hg (e.g.,  ‘ mad hatter syn-
drome ’ ) have been known for centuries, and the fi rst detailed 
account of the clinical neurotoxic syndrome induced by occu-
pational exposure to organic Hg compounds was published 
in 1940  (67) . A massive epidemic of organic Hg poisoning 
became known in the 1950s following the Minamata disease 
outbreak in Japan  (68, 69) . Subsequent studies have impli-
cated Hg in the etiology of several neurodegenerative disor-
ders, including Alzheimer disease and ALS  (70) . 
 Elemental Hg is liquid at cool room temperatures and in 
this form is less toxic than inorganic or organic Hg com-
pounds. When heated, however, Hg evaporates and becomes 
highly toxic. In an aquatic environment, elemental Hg may 
also undergo biomethylation by bacteria and algae: the 
organic compounds that are obtained, such as methyl-Hg and 
ethyl-Hg, accumulate in fi sh, crustaceans, and throughout 
the food chain to humans. These compounds can adversely 
affect human health because they are rapidly and completely 
absorbed from the gastrointestinal tract; they can bind to free 
cysteine, after which the fi nal complex may replace methion-
ine. Because of this mimicry, organic Hg compounds can be 
transported freely throughout the body and pass through the 
blood-brain barrier and the placenta, with consequent harm to 
the developing fetus  (71) . Occupational exposure to elemental 
Hg has also been associated with parkinsonism  (72) . In ani-
mal studies, inorganic Hg-chloride (HgCl 2 ) has been shown 
to concentrate in the cerebellar gray matter, area postrema, 
and hypothalamus, whereas organic Hg compounds have a 
more uniform distribution  (73 – 76) . Hg-chloride, in particular, 
induces evident nervous tissue atrophy, alongside a reduced 
number of neurons and with the proliferation of astrocytosis, 
glial fi bers, and capillary networks. The disruption of granule 
cells in rat cerebellum following dimethylmercuric sulfi de 
administration has been reported  (77) . In addition to the neu-
ronal body, Hg may damage myelin sheaths, which lose their 
laminar structure  (78 – 80) . 
 This heavy metal may damage blood-brain barrier func-
tion due to its capacity to form cross-linkages with cell 
membrane proteins, thus inducing its permeability  (81) . 
Steinwall and colleagues  (82 – 84) demonstrated that this pro-
cess occurs when Hg is administered at high dosages or is 
perfused directly into the CNS. Once the blood-brain bar-
rier is disrupted, however, Hg ions, especially in the organic 
forms  (73) , may exert various neurotoxic effects on the adult 
CNS, affecting different intracellular organelles. In the rat, 
Hg intoxication impairs protein synthesis  (85 – 87) . Hg also 
adversely affects several enzymatic activities, decreasing the 
activity of sulfhydryl enzymes such Mg-activated ATPase, 
fructose-diphosphate aldolase, and succinic deydrogenase 
 (85) , increasing acid phosphatase activity with a consequent 
accumulation in the lysosomes  (88) , impairing the glycolytic 
pathway, and decreasing ATP levels  (89) . In rat nerve cells, 
HgCl 2 markedly reduced RNA levels  (79, 80) , probably by 
two mechanisms: diminished synthesis of RNA and increased 
RNA degradation, with a consequent altered RNA turnover. 
Hg reacts with and depletes free sulfhydryl groups and deter-
mines a decline of superoxide-dismutase (SOD) activity 
leading to oxidative stress, a mechanism implicated in ALS 
pathophysiology  (90) . Interestingly, in a mouse ALS model 
overexpressing the human  SOD  type 1 [SOD1 or copper (Cu)-
zinc (Zn) SOD] gene, chronic exposure to methyl-Hg induced 
an early onset of hind-limb weakness  (69) . 
 Because ALS is characterized, among other effects, by the 
dislocation of a DNA-binding protein (TDP-43) from nucleus 
to cytoplasm, forming inclusions  (91 – 93) for a lengthy period 
 (94, 95) , Pamphlett and Jew  (94) exposed mice to different 
concentrations of inorganic Hg (the HgCl 2 vapor) for a pro-
longed time. No TDP-43 inclusions in motor neurons were 
detected, however, and the exposed mice continued to move 
and run without presenting weakness or other signs resem-
bling ALS. A single dose of HgCl 2 was shown to cause Hg 
deposition in spinal motor neurons in mice  (96) . Noteworthy 
is that in all ALS forms, TDP-43 inclusions are generally 
found, with the exception of  SOD1 mutation-associated dis-
ease, suggesting that Hg might play a role only in the lat-
ter  (95) . Neurophysiologic studies also suggested that Hg 
slows conduction velocity in dorsal roots and repolarization 
 (97, 98) . Also, low concentrations of methyl-HgCl 2 caused a 
stable increase in the threshold for excitation and blockage 
of action potentials in isolated squid axons without chang-
ing their resting membrane potentials, whereas higher con-
centrations decreased the resting membrane potentials  (99) . 
Although these studies were carried out in different experi-
mental systems, the overall results indicate that Hg intoxica-
tion in the CNS disrupts cellular metabolism and degrades 
several cellular constituents, eventually leading to cell death 
and clinical disease. Probably, the biochemical mechanisms 
and the clinical pictures of Hg toxicity in the human depend 
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on several factors, such as individual genetic susceptibility 
(specifi c polymorphisms or mutations); the chemical forms 
of the metal; and the source, length, timing, and amount of 
exposure during life. 
 In the epidemiological literature, a few studies have sug-
gested the possibility of an Hg-ALS exposure-effects linkage. 
A case of an ALS-like syndrome following exposure to organic 
Hg was described in a farmer, who presented with a 3-year 
history of progressive muscle weakness and died 8 months 
after diagnosis  (100) . The authors of this study concluded 
that exposure to Pb or Hg or excessive milk ingestion might 
have been the events leading to disease onset. Barber  (101) 
and Adams  (102) reported cases of inorganic Hg intoxication 
leading to ALS-like symptoms, with subsequent resolution 
of the disease after removal from exposure. More recently, 
Praline et al.  (103) reported the case of an 81-year-old woman 
affected by ALS who presented with a high level of Hg in the 
blood, urine, and spinal cord. Despite a therapeutic trial with 
a chelating agent, the Hg levels remained elevated, indicating 
heavy Hg body burden due to severe antecedent chronic Hg 
intoxication. An association between Hg and ALS was also 
suggested in the case of a 24-year-old man who injected him-
self intravenously with elemental Hg in a suicide attempt; he 
died 5 months later after heroin injection and wrist laceration 
but without a clinical history of ALS. Postmortem examina-
tion showed, however, dense deposits of Hg in large cortical 
motor neurons but not in other neurons, whereas all glial cells 
were occupied by Hg deposits. 
 Two studies did not fi nd an association between Hg expo-
sure and ALS. In a retrospective case-control study carried 
out on 66 patients and 66 age- and gender-matched controls, 
Gresham et al.  (104) investigated, through a self-administered 
questionnaire, exposure to nine heavy metals, including Hg 
and Se. Another  ‘ negative ’ case-control study was that con-
ducted by Moriwaka et al.  (105) in subjects living in the 
non-endemic area of Hokkaido, Japan: Hg concentrations 
in plasma, blood cells, and scalp hair were lower in 21 ALS 
patients than in their 36 controls, although such abnormali-
ties were considered by the authors to be a disease-induced 
effect. 
 In conclusion, humans exposed to various forms of Hg 
may have neurotoxic effects, including in utero and postpar-
tum exposures, but no convincing evidence has emerged for 
an involvement of this heavy metal in ALS etiology. Too few 
human studies have, however, been conducted on this issue, 
and most were affected by methodological limitations con-
cerning exposure assessment and/or confounders control. In 
addition, the results of epidemiological investigations have 
been confl icting. 
 Cadmium 
 Pure Cd is found naturally in small quantities in air, water, 
and soil. Cd in the environment occurs as a byproduct of the 
smelting of other metals, such as Zn, Pb, and Cu, and its dis-
tribution is increased due to human activities. The ingestion 
of foods, such as cereals, seafood, and offal and the inhalation 
of tobacco smoke are generally considered the main sources 
of environmental Cd exposure  (106) . Occupational exposure 
is frequently due to fume inhalation, working in the nickel 
(Ni)-Cd battery industry, and exposure to paint pigments. 
Once absorbed from the gastrointestinal tract, Cd has a long 
half-life in the body, as it is not biodegradable. 
 Cd stimulates the formation of metallothioneins (MT), a 
family of cysteine-rich low-molecular-weight metal-binding 
proteins. Experimental data support the participation of MT 
in the detoxifi cation of toxic metals, such as Cd and in scav-
enging ROS. Cd is red-ox inert as compared with other transi-
tional metals, except when conjugated with MT. The Cd-MT 
complex is formed in the liver, released into the blood, and 
transported to the kidneys  (107, 108) . Acute Cd poisoning 
causes pulmonary edema and hemorrhage; chronic exposure 
adversely affects kidney and bone  (109) . Cd also acts as an 
endocrine disruptor  (110, 111) and may thus affect repro-
duction and child development  (112) . In addition, Cd and 
its compounds are classifi ed by the International Agency for 
Research on Cancer as a group 1 human carcinogen based on 
evidence that lung cancer is increased in Cd workers  (113) . 
Cd exposure has also been linked to human prostate and renal 
cancer, although this linkage is weaker than for lung cancer 
 (114) . The role of the metal in liver, pancreas, and stomach 
carcinogenesis is considered equivocal  (115) . 
 Some of the toxicological effects of Cd mirror the bio-
chemical mechanisms underlying ALS pathophysiology, 
thus providing biological plausibility to a Cd-ALS relation. 
In particular, considering that 20 % of familial ALS cases 
show  SOD1 gene mutations  (5) , the capacity of Cd to alter 
SOD1 activity is of considerable interest. Cd can induce 
MT expression  (116) , which may act as a protective factor 
against ROS, but this protein also binds Zn ions in mam-
malian cells in addition to Cd  (117) , irreversibly decreasing 
SOD1 enzyme activity  (118) . Moreover, Cd can interfere 
with the secondary structure of the SOD1 protein by decreas-
ing its Zn content and thus enzymatic activity  (109) and by 
inducing misfolding and aggregation of the SOD1 protein 
 (119) . These effects were analyzed by spectroscopy, which 
showed that Cd modifi es SOD1 conformation by increasing 
the  α -helix structure and decreasing the random coil domain. 
Cd also induces SOD1 cytoplasmic inclusions in the proximal 
axon and neuron cell body, which represent the pathological 
fi ndings detected in motor neurons and astrocytes from ALS 
patients  (120) . Degeneration of the neural tube in Cd-treated 
embryos of zebra fi sh has also been demonstrated  (121) . In 
particular, if the animal embryos are exposed to Cd before 
neurulation, a gap in the anterior neural tube is observed, 
and if exposure follows the closure of the neural tube, upper 
limb defects may occur  (122, 123) . Other studies confi rmed 
that Cd induces cell apoptosis, especially in mouse N2A neu-
roblastoma cells.  (109) . The mechanism through which Cd 
induces programmed cell death is not clear, but proteomic 
studies identifi ed differences of protein expression and aggre-
gation between control and Cd-treated N2A cells, involving 
structural proteins, stress-related and chaperone proteins, 
ROS enzymes, apoptosis, and survival signals  (109) . 
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 In the epidemiological literature, of interest is the observa-
tion by Pamphlett et al.  (124) of higher blood Cd concentra-
tions in 20 ALS patients compared with controls. Successive 
studies measuring heavy metal levels in ALS patients have 
produced contradictory results, but in most investigations, 
Cd appeared to be increased. Bar-Sela et al.  (125) reported in 
2001 a case of a 44-year-old patient who died from ALS after 
9 years of Cd exposure while working in a Ni-Cd battery plant 
in Israel. The work conditions and exposures in that plant 
were extremely hazardous, and the exposure of this patient 
was considerably more intense than that characterizing his 
coworkers. In particular, the patient had to shake the barrels 
to loosen up chunks of Cd, a process releasing Cd-containing 
fumes. As soon as ALS was diagnosed, the blood Cd level 
was 8  μ g/L, 10-fold higher than in non-smoking Israelis, but 
this concentration might not refl ect the long-term antecedent 
exposure because blood Cd levels are known to fall rapidly 
when exposure ends  (126) . The urinary Cd level, an indicator 
of cumulative past exposure, was 13  μ g/L  (125) . The epidemi-
ological data are extremely limited, but the available evidence 
suggests that occupations and workplace Cd exposure may be 
linked with excess ALS risk, but there could have been a con-
tributory role for solvent. The patient was one of many with 
neurotoxic type syndromes, and many other effects associated 
with mixed exposures to Cd, Ni, and solvents in appalling 
working conditions  (127) . A case-control study carried out in 
New England between 1993 and 1996 showed a higher risk 
of ALS for construction workers [odds ratio (OR) = 2.9; 95 % 
CI, 1.2 – 7.2] and precision metal workers (OR = 3.5; 95 % CI, 
1.2 – 10.5), but establishing what compounds  – including Cd  – 
were specifi cally involved was impossible  (128) . In accor-
dance, other research gave support to the hypothesis that ALS 
patients are more likely to have been exposed to heavy metals 
compared with controls  (129 – 131) . 
 On the other hand, Pierce-Ruhland and Patten  (132) were 
unable to detect long-term excessive exposure to Cd in ALS 
patients, although overall exposure to heavy metals, such 
as Pb and Hg appeared to be related to disease risk. Their 
study encompassed 80 MND patients and 78 controls using 
telephonic interviews. In another case-control study from 
Australia, no correlation between ALS and antecedent occupa-
tional exposure to Cd or other metals (as ascertained through 
questionnaires) was found when analyzing 179 disease cases 
and a corresponding number of controls  (133) . Interestingly, 
in an older study based on autopsy samples carried out on 24 
patients with ALS and 18 controls, an elevated level of MT in 
liver and kidneys of patients was detected  (134) , which may 
be of considerable interest for ALS etiology, considering the 
interrelation between MT and Cd. 
 In summary Cd, a recognized neurotoxic element, is 
assumed to be involved in ALS etiology on the basis of spe-
cifi c biological plausibility supporting this view, but epidemi-
ological evidence is still lacking due to the very few number 
of studies (generally with low statistical power) carried out 
to date. Additionally, despite various international guidelines 
from the 1990s that have banned the use of Cd in plastic, 
PVC, batteries, and electronics and have led to a decrease 
in Cd occupational exposure, little evidence has emerged of 
decreased ALS incidence [which, on the converse, might be 
increasing  (2) ]. Thus, although Cd might be involved in ALS 
etiopathogenesis, such a relation is still far from being dem-
onstrated and we need more reliable data to assess it. 
 Lead 
 Pb is a naturally occurring metal that is present in small 
amounts in the earth ’ s crust. In the environment, Pb derives 
mainly from human activities, including burning fossil fuels, 
mining, and manufacturing. Pb is used in the production of 
batteries, ammunition, metal products (solder and pipes), and 
devices to shield X-rays. Due to health concerns, Pb from 
gasoline, paints and ceramic products, caulking, and pipe sol-
der has been reduced in recent years; hence, cases of overt Pb 
poisoning have become less frequent  (135) . The toxic effects 
of Pb on the nervous system are well known and include Pb 
encephalopathy (primarily in children) and a peripheral motor 
neuropathy (primarily in adults)  (136) . After absorption from 
the gut, Pb is deposited in the soft tissues (liver, kidney, eryth-
rocytes), and then transferred to the bones, where it is stored 
in a biologically inactive form. Bone Pb levels increase with 
age  (135) . The half-life of Pb is 1 month in blood, 3 – 5 years 
in trabecular bones, such as patella, and 15 – 25 years in corti-
cal bones, such as tibia. Hence, blood Pb is generally consid-
ered to refl ect acute exposure, whereas bone Pb is believed 
to refl ect cumulative exposure. Prolonged exposure results in 
increased bone Pb concentration that persists after the termi-
nation of the original exposure  (137) . 
 With regard to ALS, the mechanisms underlying Pb neuro-
toxicity make the relation of Pb to ALS biologically plausible 
because Pb neurotoxicity depends on the same mechanisms 
suggested for the pathogenesis of this disease. The pathophys-
iological mechanisms underlying the development of ALS 
appear to be multifactorial, with emerging evidence of a com-
plex interaction between genetic and environmental factors. 
In the last years, in addition to the SOD1 gene, new genes 
have been discovered (TDP43, FUS, VCP, etc.) that can act 
synergistically with environmental factors through different 
pathogenetic mechanisms. Such mechanisms include gluta-
mate neurotoxicity, oxidative stress, mitochondrial or axonal 
transport dysfunction, autophagy, and protein misfolding. 
An excessive activation of these postsynaptic receptors by 
glutamate, known as glutamate-induced excitotoxicity, can 
incite neurodegeneration through the activation of calcium-
dependent enzymatic pathways. Glutamate-induced excito-
toxicity can also result in the generation of free radicals, which 
in turn can cause neurodegeneration by damaging intracellu-
lar organelles and up-regulating proinfl ammatory mediators 
 (138) . Oxidative stress might also be caused by the toxic gain 
of function of the SOD1 enzyme following SOD1 mutation 
 (139) . In addition, structural abnormalities of mitochondria, 
dysfunction of the sodium/potassium ion pump, autophagy, 
and disrupted axonal transport systems have all been impli-
cated in ALS pathogenesis  (138) . Non-neuronal cells, such 
as astrocytes and microglia, might also directly contribute to 
neurodegeneration through mechanisms including insuffi cient 
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release of neurotrophic factors, secretion of neurotoxic media-
tors, and modulation of glutamate receptor expression (known 
as noncell autonomous neurodegeneration)  (140) . Another 
possible pathogenetic mechanism involves protein misfold-
ing. SOD1 mutations induce conformational instability and 
misfolding of the SOD1 peptide, resulting in the formation 
of intracellular aggregates that inhibit normal proteosomic 
function, disrupting axonal transport systems and vital cel-
lular functions. The TAR DNA binding protein 43 (TDP-43) 
has also been recognized as a major component of ubiquit-
inated cytoplasmic protein aggregates in almost all patients 
with sporadic ALS (sALS)  (141) . Aggregates of another pro-
tein, the fused-in sarcoma protein (FUS), were found in ALS 
but not in patients with pathological changes in TDP-43 or 
SOD1, indicating a novel disease pathway  (142) . Pb can also 
substitute for calcium in many intracellular reactions, damage 
mitochondria, and amplify glutamate excitotoxicity  (143) . 
Animal studies have suggested that ALS onset may be related 
to motor neuron function, whereas progression is regulated 
by neuroglia  (144) . 
 Surprisingly, Pb might injure motor neurons and at the 
same time stimulate glial cells to provide trophic support to 
neurons and therefore delay cell death. Experimental evi-
dence supports the view that astrocytes can sequester and 
buffer Pb in the CNS, preventing further diffusion of the 
metal to the neuronal compartment and subsequent neuro-
toxicity or altered synaptic transmission  (145, 146) . In par-
ticular, astrocytes are the cells that preferentially induce 
cytoprotective and antioxidant gene expression in response 
to Pb  (147) . When pretreated with low, non-toxic Pb concen-
trations, astrocytes can induce neuroprotective mechanisms, 
such as the up-regulation of VEGF (vascular endothelial 
growth factor) gene expression, and can down-regulate neu-
roinfl ammation, as shown by a dramatic reduction of GFAP-
immunoreactive astrocytes  (148) . Accordingly, Barbeito and 
colleagues  (149) found that Pb exposure prolonged survival 
in SOD1 transgenic mice. 
 Hence, Pb exposure could potentially have opposing 
actions during the course of ALS, initially promoting the 
degeneration of motor neurons but later abrogating damage 
and neuroinfl ammation mediated by dysfunctional glia  (148) . 
Additionally, Pb decreases SOD activity in Pb-exposed rats 
 (150) and stimulates antioxidant enzyme hemoxygenase 1 
expression in astrocytes  (147) , mechanisms that could con-
tribute to neuronal protection. Alternatively, another possi-
bility is that factors associated with better survival are also 
associated with higher Pb levels in the population, such as 
gender (men have higher Pb levels and longer ALS survival) 
but not age because older individuals have higher Pb levels 
but shorter ALS survival  (151) . Another possibility is that Pb 
exposure is related not to ALS risk but rather to longer sur-
vival, favoring the higher participation of Pb-exposed cases 
in epidemiological studies, thus being a source of selection 
bias  (151) . Another possibility is that of reverse causality, i.e., 
Pb levels are a result of ALS due to the decline in physical 
activity in ALS patients, leading to bone demineralization 
and the release of Pb from bone into blood, as also suggested 
by the direct correlation between blood Pb and disability due 
to the disease in a case-control study  (54) . Nevertheless, the 
associations of blood and bone Pb in ALS patients were not 
appreciably changed by adjusting for physical activity levels 
 (143, 152, 153) or by bone turnover  (152) . 
 In epidemiological studies, Pb exposure has long been 
investigated as a potential ALS risk factor and as a factor 
affecting survival in this disease  (154) . In the fi rst report on 
progressive muscular atrophy by Aran  (155) in 1850, 3 of 11 
cases had contact with Pb, and in 2 cases, Pb poisoning was 
diagnosed. A number of cases with lower motor neuron signs 
and pyramidal involvement can be dated at the fi rst years of 
the 20th century. More recently, Oh et al.  (156) reported a 
case of ALS in a worker who was exposed to Pb while work-
ing in electronic parts manufacturing. Besides single case 
reports, a number of case-control studies and registry-based 
case-control or cohort studies have dealt with this topic. The 
majority of the case-control studies  (104, 131, 132, 143, 152, 
154, 157 – 159) found some evidence for an association of 
ALS with Pb exposure as estimated through the administra-
tion of questionnaires. In 1970, Campbell et al.  (154) , through 
a case-control study on 74 patients with MND and 74 age- 
and gender-matched controls, found a history of extensive Pb 
exposure in 15 % of patients and in 5.4 % of the controls and 
a history of bone disease or fracture in 25 % of patients and 
in 9.4 % of the controls. The authors also found a 54 % 5-year 
survival rate in MND patients previously exposed to Pb vs. 
16 % in patients without antecedent Pb exposure. Increased 
Pb exposure and increased frequency of bone fractures could 
suggest a role of toxic Pb reservoir for the bone, which may 
release Pb after traumatic events, thus contributing to ALS 
onset. Yet, the authors did not fi nd different bone Pb levels 
in the two groups. Felmus et al.  (157) studied the anteced-
ent events of Pb exposure in 25 patients with ALS and 50 
controls, detecting a higher exposure to Pb, Hg, athletics, 
and consumption of milk in patients compared with controls 
 (157) . This study was replicated in 1981 with confi rmation of 
the results  (132) . Armon et al.  (158) found that men with ALS 
had worked more frequently at welding and soldering, sug-
gesting an association between ALS in men and exposure to 
Pb vapors. In a study from the Scottish MND Register carried 
out on 103 ALS patients and their matched controls, history 
of fractures (OR = 1.3), manual occupation (OR = 2.6), and 
exposure to Pb (OR = 5.7), and solvents/chemicals (OR = 3.3) 
was more frequent in patients  (131) . Other studies, however, 
did not confi rm these results  (104, 160, 161) . Nevertheless, 
the validity of the early data is still debated. These studies 
include occupational exposures that epidemiologists often 
use as a surrogate to assess potentially toxic exposures, and 
many studies relied on self-reporting through questionnaire 
use, an approach at risk of recall bias. Indeed, McGuire 
et al.  (159) reported that Pb exposure based on expert evalu-
ation of self-reported occupational histories by a panel of 
industrial hygienists was not associated with ALS (OR = 1.1), 
suggesting that recall bias might explain fi ndings obtained on 
the basis of self-reported data. In another study  (143) , occu-
pational Pb exposure based on review of self-reported occu-
pational history was associated with ALS, and the RR was 
similar to that computed for self-reported Pb exposure. More 
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recently, blood Pb levels were found to be increased among 
US veterans affected by ALS compared with controls  (152) , 
suggesting that Pb exposure might at least in part explain the 
higher risk of ALS noted for military personnel, who can be 
exposed to Pb from fi ring and other practices. Residential and 
recreational Pb exposure might also represent a risk factor 
for ALS, but such exposures are generally lower than those 
experienced in occupational settings and therefore more dif-
fi cult to investigate due to a high risk of misclassifi cation. 
In the Italian province of Modena, ALS rates were higher in 
residents in the  ‘ ceramic district ’ , where several paving-tile 
factories were located and induced a severe environmental Pb 
pollution than in the unexposed population  (162) . However, 
this excess incidence was not confi rmed in following studies 
carried out in the same province  (163) or in the neighboring 
province of Reggio Emilia  (164) , although the possibility of 
delayed effects of such extensive Pb contamination cannot yet 
be ruled out. 
 Several studies examined the Pb-ALS relation through an 
analysis of biomarkers of exposure, but their results were 
inconsistent. Studies from one group reported that, compared 
with controls, ALS cases had higher Pb levels in plasma 
 (165) , cerebrospinal fl uid  (166) , and muscle  (165) . Kurlander 
and Patten  (167) reported that even after chelation therapy, 
postmortem concentration of tissue metals was consistently 
increased. Other studies yielded null results  (168 – 172) , 
including the population-based investigation by Bergomi 
et al.  (55) on toenails trace elements concentrations in 22 ALS 
patients and 44 matched controls. In this study, no evidence of 
an association between ALS risk and toenails trace elements 
(including Pb) was detected. 
 All the above-mentioned studies have limitations, includ-
ing small size, possible confounding by uncontrolled factors 
affecting Pb levels, and potential bias introduced by the use 
of hospital-referred controls in some cases. Several factors 
related to blood and bone Pb levels, including age, gender, 
cigarette smoking, alcohol use, and education, are known to 
be potential confounders in the Pb-ALS relation. A recent 
study, however, combined biological measures and inter-
views to analyze this issue  (143) . The authors studied 109 
cases and 256 controls and found that ALS risk was associ-
ated to self-reported occupational Pb exposure (OR = 1.95) 
and also with increased blood and bone Pb levels, with 
OR = 1.9 for each  μ g/dL increase in Pb blood levels, OR = 3.6 
for each unit increase in log-transformed patella Pb, and 
OR = 2.3 for each unit increase in log-transformed patella 
Pb. The same group also found that Pb exposure was associ-
ated with longer survival in ALS cases  (151) , an observa-
tion apparently contrasting with the previous observation 
of an excess disease risk in Pb-exposed subjects  (143) . The 
same confl icting results had been previously reported by 
Campbell et al.  (154) in the 1970s, which may indicate that 
Pb exposure might have different effects on ALS onset and 
progression. 
 In conclusion, the data on Pb as a possible risk factor for 
ALS are confl icting and inconsistent, and methodological 
limitations of the epidemiological studies hamper reaching 
defi nitive conclusions about this issue. Nevertheless, the 
possibility that Pb exposure increases ALS survival deserves 
further evaluation. 
 Pesticides 
 The four major classes of pesticides include insecticides, her-
bicides, fungicides, and rodenticides, based on target species, 
plus other pesticides included in narrower classifi cations. In 
the human, exposure to pesticides can occur through the oral, 
dermal, or inhalation route. Although some pesticides are neu-
rotoxic, these are not generally classifi ed as such. Among pes-
ticides, the organophosphates (OPs, as insecticides) have been 
associated with ALS following the report of increased inci-
dence of ALS in Persian Gulf War veterans, but no conclusive 
epidemiological evidence supports this apparent increased 
risk  (69) . Returning 1991 – 1992 veterans were reported to 
have received prophylactic treatment containing cholinergic 
inhibitors to protect them against nerve gas and insect pests, 
and plausibly, such pretreatment could have exacerbated an 
underlying genetic polymorphism or unmasked other factors 
that increase the risk of motor neuron effects. The OPs have 
wide agricultural and home uses. 
 The primary toxicity of OPs is associated with the acute 
inhibition of acetyl cholinesterase, the enzyme responsible 
for the destruction and termination of the biological activity 
of the neurotransmitter acetylcholine  (173 – 175) . A second 
distinct manifestation of OP poisoning is a paralytic condi-
tion called the intermediate syndrome, which consists of a 
sequence of neurological signs appearing about 24 – 96 h after 
the acute cholinergic crisis but before the onset of delayed 
neuropathy. The major effects are muscle weakness, primar-
ily affecting muscles innervated by the cranial nerves (neck 
fl exors, muscle of respiration) as well as those of the limbs. 
Cranial nerve palsies are common, respiratory depression and 
distress are not responsive to atropine or oximes, and death 
may occur. A third syndrome is the OP-induced delayed neu-
rotoxicity (or OP-induced delayed polyneuropathy), in which 
the agent binds with neurotoxic esterase without effects on 
ChE  (176) . 
 Other clinical signs and symptoms from impairment of 
ChE in muscarinic, nicotinic, and central sites are headache, 
dizziness, paralysis, ataxia, bradycardia, miosis, weakness, 
anxiety, excessive sweating, fasciculations, vomiting, diar-
rhea, abdominal cramps, dyspnea, salivation, tearing, pulmo-
nary edema, and confusion. 
 No studies have been designed to specifi cally investigate 
the potential association of OPs with ALS. Morahan et al. 
 (177) analyzed the potential of pesticides, heavy metals, and 
chemicals to cause sALS and showed that an impaired capac-
ity of patients to detoxify these toxicants could be related to 
differences in the MT family of genes, metal transcription 
factor 1 and glutathione synthetase. 
 Other studies examined paraoxonase (PON) genes in the 
investigation of the potential association as described by 
Johnson and Atchison  (69) . PON is an A-esterase based on 
its ability to detoxify the prototype OPs, paraoxon. PON1 
detoxifi es OPs and has several variants, i.e., PON1, PON2, 
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and PON3. PON hydrolyses OPs, and its ability to detoxify 
them is largely determined by different variants of PON1 
as opposed to other variants. Genetic variations have been 
found in the coding and promoter region of the human PON1 
locus that determines the catalytic activity and enzyme lev-
els. Therefore, theoretically, the risk of developing ALS in 
an individual could increase if the mutation of the PON1 
gene increases and if the body concentration of PON1 is 
suboptimal. Thus, mutations that impair the ability of PON1 
to detoxify OPs could increase sensitivity to the toxicity of 
these pesticides and possibly of Pb, favoring ALS develop-
ment, as well as the other effects specifi cally associated with 
anticholinesterases. No consistency has emerged, however, in 
establishing a causal link between OPs exposure and muta-
tions in the PON1 gene, based on epidemiological and animal 
studies. Wills et al.  (178) showed that the polymorphism of 
PON1 genes did not reduce enzyme activity, suggesting that 
this gene product is unlikely to be involved in ALS etiology. 
Other studies suggest that among veterans with Gulf War 
syndrome, US veterans have signifi cantly lower serum con-
centrations of one form of PON1 allozyme, whereas British 
veterans have lower concentrations of both allozymes (Q and 
R allozymes), when compared with healthy Gulf War veter-
ans  (178) . A report of two cases has shown massive increases 
in CPK  – a measure of the breakdown of muscle tissue  – in 
persons with occupational exposure to highly toxic anticho-
linesterases  (179) . The authors ’ suggestion that medical pro-
grams for Gulf War veterans with Gulf War syndrome should 
include surveillance for elevated CPK, abnormalities of neu-
romuscular conduction, and genetic susceptibility to guide 
diagnosis and care may also be of value in helping to sort out 
the possibility of mixed causes. 
 A case of a slowly progressive MND following chronic 
exposure to pyrethroids that was indistinguishable from ALS 
was reported in a 44-year-old woman who, as a food shop 
proprietor, had been using cans of pyrethroid insecticides 
containing imiprothrin, phenotorin, D-T80-resmethrin, and 
D-T80-phthalthrin almost every day for 3 years in an unven-
tilated room  (180) . Further description follows:
 Initially, she experienced tongue numbness, nausea, 
and rhinitis while using the insecticides. Two years 
after beginning to use the insecticides, she noticed dif-
fi culty lifting heavy objects with her left arm, and her 
symptoms steadily worsened over the next 8 months. 
Three months before admission, she developed slurred 
speech, gait disturbance, and generalized muscle weak-
ness. On admission, neurological examination revealed 
dysarthria, nasal voice, and dysphagia with fasciculat-
ing atrophied tongue, moderate muscle weakness with 
fasciculation in both upper limbs, predominantly on the 
left side, and fasciculation in the trunk and both lower 
limbs. Jaw jerk was hyperactive, and hyperrefl exia was 
seen in all limbs without pathological refl exes. Sensory 
and autonomic systems were all normal.  The patient 
showed upper and lower motor neuron signs in bulbar, 
cervical, and lumbosacral regions, consistent with signs 
in bulbar, cervical, and lumbosacral regions, suggesting 
clinically defi nite ALS based on El Escorial criteria. 
Neurophysiologic studies also indicated both upper 
and lower motor neuron involvement. Her illness was 
thought to be caused by pyrethroids for two reasons: 
[1] the usual manifestations of pyrethroid intoxication, 
such as tongue numbness, nausea, and rhinitis, pre-
ceded the motor dysfunction; [2] the motor symptoms 
and ongoing denervation potentials partially improved 
after the cessation of pesticide usage. The case indi-
cates that chronic pyrethroid intoxication may cause an 
ALS-like disorder in humans, similar to Pb and domoic 
acid intoxications. Pyrethroids are synthesized from 
chrysanthemum extracts, and they disturb ion chan-
nels, such as voltage-dependent sodium channels and 
voltage-sensitive chloride channels, and readily induce 
neuronal excitation by current prolongation. Moreover, 
deltamethrin, one of the pyrethroids, is reported to 
impair axonal transport and then degenerate axons in 
rats, with impaired axonal fl ow causing motor neuron 
death in various animal models of MND. Although 
pyrethroids have low toxicity, due in part to their rapid 
detoxifi cation via ester hydrolysis in mammals, some 
human populations are thought to be poor metabolizers 
of pyrethroids, whereas carboxyesterase inhibitors can 
enhance pyrethroid toxicity. Therefore, chronic expo-
sure to pyrethroids may cause MND through distur-
bance of either ion channels or axonal fl ow, especially 
in poor metabolizers  (180) . 
 A case simulating MND closely associated with overexpo-
sure to a pyrethrin and chlordane-based insecticide has also 
been reported  (181, 182) . For pyrethrins, such as pymethrin, 
the elimination of metabolites 4 ′ -hydroxy-3-phenoxy benzyl 
alcohol or 4 ′ -hydroxy-3-phenoxy benzoic acid occurs by sul-
fate conjugation, which is the major metabolic pathway in the 
rat. MND patients have a defect in their ability to convert 
cysteine into inorganic sulfate and also show a poor capacity 
to form the sulfate conjugate of paracetamol. Therefore, these 
two metabolites may be responsible for neurotoxic effects, 
resulting in MND-type illness. 
 In human populations, various investigators have exam-
ined the potential association of pesticide exposure with 
ALS risk. Studies have been conducted in different coun-
tries, including Italy (Ferrara, Reggio Emilia, and Sardinia), 
France (Britanny), USA (states of Massachusetts, Michigan, 
Minnesota, and Washington), Scotland, Sweden (Scaraborg), 
Australia (all states), and Greece (Athens), as summarized in 
Table  1 . Included are reports that referred to MND and ALS 
interchangeably, reports that include ALS as one type of MND, 
and reports that referred to all MND with no mention of ALS, 
plus reports that are literature reviews of some of the studies. 
Table 1 also summarizes the methodological strengths and 
the weaknesses of these studies. The human studies reported 
on the potential association of pesticides to ALS, or the lack 
thereof, are also shown in Table  2 .  ‘ Potential association ’ is 
based on increased rates or risk in the exposed subjects, sug-
gesting a possible but not defi nitive role of pesticides, taking 
into account occupation in an agricultural environment, being 
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a farmer, or environmental risk factors, such as contact with 
soccer fi elds assumed to have been treated with herbicides. 
The pattern relating ALS to occupational exposure is incon-
sistent, as, in addition to agriculture and farming, some stud-
ies reported associations of ALS with different occupations, 
such as heavy metal work, electric trauma, use of pneumatic 
tools, employment in the plastics industry, exposure to heavy 
metals, acids, and animal carcasses, and truck driving  (193) . 
Even when farmers were identifi ed, the subjects might not be 
the traditional thinking of farmers who use pesticides (e.g., 
pesticide applications for agricultural crops), but rather sheep 
breeders as in the case reported by Rosati et al.  (196) . Of the 
18 reports, 13 suggest a weak potential association, and fi ve 
do not report any association. The potential association is 
examined mainly in terms of occupation and environmental 
risk factors, generally using existing records of ALS patients 
along with control populations and questionnaire surveys. A 
major weakness of these studies is inadequate exposure assess-
ment due to insuffi cient information on the actual chemicals 
involved or about their use (amount, application method), 
exposure pattern (air, dermal; intermittent; short, medium, or 
long-term; job category), frequency (hours, daily, monthly), 
duration (total time period), level of exposure (measured 
concentrations), industrial hygiene (protective measures). 
Much of the potential association is assumed (e.g., assumed 
exposure to pesticides because of agriculture-related work), 
with no specifi c pesticide products identifi ed. That the studies 
were conducted in the different parts of the world offers some 
level of  ‘ consistency ’ , which is a key aspect of causal infer-
ence, although no cause-effect relation was clearly identifi ed. 
Nevertheless, a suggestion of consistent results can be seen 
across studies from different areas and different researchers, 
using different methods and subjects. Other limitations of 
these studies include small sample size  (183, 187) , unavail-
able information about confounders, such as lifestyle (e.g., 
diet, smoking), and other chemical exposures (e.g., chemicals 
used on farms, in hobbies). Another limitation is the self-re-
porting nature of certain studies, which might be a subjec-
tive process and also may carry recall and selection biases 
 (133, 185, 187) . Therefore, that the increased ALS incidences 
observed in these studies were actually caused by pesti-
cides cannot be defi nitively confi rmed, although the overall 
evidence is suggestive of an association between increased 
ALS risk and pesticide exposure. 
 As noted above, one potential relation of pesticides to 
MND is the neurotoxic properties of several pesticides, such 
as OPs pesticides, and the genetic susceptibility of individuals 
to such toxicity. As PONs are involved in the detoxifi cation of 
this group of pesticides, studies have been conducted to exam-
ine the potential association between sALS and  PON gene 
cluster variants. Saeed et al.  (197) investigated the associa-
tion between sALS and  PON gene cluster variants in a large 
North American Caucasian family-based and case-control 
cohort. Clinically defi nite and probable ALS was diagnosed 
according to the revised El Escorial criteria, exclusion of 
family history of ALS, and  SOD1 mutation analysis. Single-
nucleotide polymorphism (SNP) genotyping was done using 
TaqMan gene expression assay. A haploblock of high linkage 
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 Table 2  Summary of reports on human studies on potential association of pesticides to ALS. 
References a Potential association b Characteristics used to link study subjects to pesticides c 
Bonvicini et al., 2010  (183)  + Agricultural work
Furby et al., 2010  (184)  + Contact with agricultural chemicals
Weisskopf et al., 2009  (185)  – No background information (e.g., occupation). American Cancer 
Society Cancer Prevention study participants self-reporting on 
exposure to 11 different chemicals classes or X-rays
Chio et al., 2009  (186)  + Soccer players
Qureshi et al., 2006  (187)  + No background information (e.g., occupation). Neuromuscular 
clinic patients self  – reporting on toxic exposures.
Morahan and Pamphlett, 2006 
 (133) 
 + No background information (e.g., occupation). ALS patients 
self-reporting on pesticide/herbicide exposures
Govoni et al., 2005  (188)  + Occupation in agricultural work
Burns et al., 2001  (189)  + Manufacture or formulation of 2,4-D
McGuire et al., 1997  (159)  + Exposure to agricultural chemicals (in men)
Gunnarsson et al. 1991  (193)  + Farm workers (and offi ce workers)
Giagheddu et al., 1983  (194)  + Farm workers
Holloway et al., 1982  (195)  + / – (frequency of exposure 
9 % in patients and 5 % in the 
control population)
Farmers and agricultural workers (including three clinical 
variants of MND: progressive muscular atrophy, progressive 
bulbar palsy, and ALS).
Rosati et al., 1977  (196)  + Agricultural workers, mainly farmers (majority sheep breeders)
 
a
 The limitations of the studies are summarized in Table 1 and discussed in the text.  b ‘ Potential association ’ ( + ) is based on increased incidence 
or RR when the exposed population is compared with the unexposed one, suggesting a possible but not a defi nitive role of pesticides.  c ‘ Potential 
association of pesticides ’ to ALS is inferred or assumed based on potential association of increased incidence or RR with characteristics that 
linked study subjects to pesticides, such as occupation in an agricultural environment, being a farmer, or reports on environmental risk factors 
(e.g., contact with soccer fi elds assumed to have been treated with herbicides). 
disequilibrium (LD) spanning  PON2 and  PON3 was associ-
ated with sALS. The SNPs rs10487132 and rs11981433 were 
in strong LD and associated with sALS in the trio (parents-
affected child triad) model. The association of rs10487132 
was replicated in 450 nuclear pedigrees comprising trios and 
discordant sibpairs. No association was found in case-control 
models, and their haplostructure was different from that of 
the trios with overall reduced LD. Resequencing identifi ed an 
intronic variant (rs17876088) that differentiates between det-
rimental and protective sALS haplotypes. The authors con-
cluded that there is an association of variants in the PON gene 
cluster with sALS, which is compatible with the hypothesis 
that environmental toxicity in a susceptible host may precipi-
tate ALS. 
 Some PON1 promoter polymorphisms may predispose to 
sALS, possibly by making motor neurons more susceptible to 
OP-containing toxins. To determine whether an impaired abil-
ity to break down OPs underlies some cases of sALS, Morahan 
et al.  (177) studied 143 sALS patients and 143 matched con-
trols and compared frequencies of PON1 polymorphisms, 
investigating gene-environment interactions based on infor-
mation on self-reported pesticide/herbicide exposure. The 
PON1 promoter allele 108t, which reduces PON1 expression, 
was strongly associated with sALS. Overall, promoter hap-
lotypes decreasing PON1 expression were associated with 
sALS, whereas haplotypes increasing expression were asso-
ciated with controls. 
 Wills et al.  (178) tested the hypothesis of an association 
that correlates with functional changes in PON1 (PON1, 
MIM 168820) within a case-control study. Sera from 140 
ALS patients and 153 matched  ‘ healthy ’ controls and CSF 
samples from 15 patients and 15 controls were tested for 
PON, diazoxonase, and arylesterase activities. Participants 
with ALS were genotyped using tagging SNPs across the 
PON locus, and survival data and enzyme activity were cor-
related with genotype. A trend toward increased PON activity 
was noted in ALS compared with controls, which correlated 
with increased frequency of the homozygous arginine (RR) 
variant of PON1Q192R. Contrary to expectations, PON1 
protein, PON1, diazoxonase, and arylesterase activities were 
not reduced in ALS patients. OP hydrolysis rates had no 
effect on ALS survival. The authors noted that the increase in 
PON1R192 frequency in ALS in this study supported previ-
ous genetic susceptibility studies, and the fi ndings suggested 
that the infl uence of PON1 polymorphisms on ALS suscepti-
bility was not due to reduced OPs hydrolysis. A limitation of 
this study, however, is the lack of a population-based design 
for cases and controls, an approach that might have been 
responsible for selection bias. 
 Conclusions 
 Overall, our analysis supports the view that Se and pesticides 
are likely to be involved, either as triggering factors or as 
causal agents, in ALS etiology, based on epidemiological evi-
dence and some biological plausibility. The evidence is par-
ticularly impressive for Se due to its selective toxicity to motor 
neurons. Less suggestive is the involvement of Hg, Cd, or Pb 
in disease etiopathogenesis due to the limited evidence from 
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both epidemiological and laboratory studies and because the 
studies carried out thus far are inconclusive. Apart from the 
PONs genes, little is known about the possible role of genetic 
susceptibility in mediating the effects of environmental toxins 
in triggering ALS onset. Various methodological limitations of 
the studies, such as low statistical power, exposure misclassi-
fi cation, and inadequate control of confounders, might explain 
the confl icting results found in the literature on these issues. 
Further in-depth investigation of the involvement of Se, heavy 
metals, and pesticides in ALS etiology is warranted. 
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